Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

文献类型： 外文期刊

第一作者： Chen, Xiangyu

作者： Chen, Xiangyu;Pan, Zhiwei;Yue, Shuai;Yang, Yang;Gao, Leiqiong;Li, Zhirong;Lin, Yao;Xu, Lifan;Tang, Jianfang;Hu, Li;Ye, Lilin;Yu, Fei;Liu, Bingfeng;Yang, Xiaofan;Deng, Kai;Zhang, Junsong;Li, Ren;Li, Ren;Huang, Qizhao;Zhao, Jing;Liu, Pinghuang;Zhang, Guozhong;Chen, Yaokai;Deng, Kai

作者机构：

期刊名称：SIGNAL TRANSDUCTION AND TARGETED THERAPY （ 影响因子：18.187； 五年影响因子：21.177 ）

ISSN： 2095-9907

年卷期： 2020 年 5 卷 1 期

页码：

收录情况： SCI

摘要： COVID-19 patients exhibit differential disease severity after SARS-CoV-2 infection. It is currently unknown as to the correlation between the magnitude of neutralizing antibody (NAb) responses and the disease severity in COVID-19 patients. In a cohort of 59 recovered patients with disease severity including severe, moderate, mild, and asymptomatic, we observed the positive correlation between serum neutralizing capacity and disease severity, in particular, the highest NAb capacity in sera from the patients with severe disease, while a lack of ability of asymptomatic patients to mount competent NAbs. Furthermore, the compositions of NAb subtypes were also different between recovered patients with severe symptoms and with mild-to-moderate symptoms. These results reveal the tremendous heterogeneity of SARS-CoV-2-specific NAb responses and their correlations to disease severity, highlighting the needs of future vaccination in COVID-19 patients recovered from asymptomatic or mild illness.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序